11:38 AM EST, 11/11/2025 (MT Newswires) -- Salarius Pharmaceuticals ( SLRX ) said Tuesday it has priced an underwritten public offering of securities to raise about $7 million.

The offering is comprised of about 2.5 million shares and pre-funded warrants to purchase some 2.2 million shares, in each case with accompanying series A and series B warrants to buy up to around 4.7 million shares, the company said.

The offering price is $1.50 per share and accompanying warrants, Salarius said. It expects to close the offering Nov. 12.

Net proceeds will be used for clinical development, promissory notes repayment, and for general corporate purposes, it said.

Shares of Salarius were down about 46% in recent trading.

Price: 1.00, Change: -1.00, Percent Change: -50.00